Satoshi Soen

4.1k total citations
82 papers, 2.9k citations indexed

About

Satoshi Soen is a scholar working on Orthopedics and Sports Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Satoshi Soen has authored 82 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 49 papers in Orthopedics and Sports Medicine, 35 papers in Oncology and 24 papers in Molecular Biology. Recurrent topics in Satoshi Soen's work include Bone health and osteoporosis research (41 papers), Bone health and treatments (33 papers) and Bone Metabolism and Diseases (21 papers). Satoshi Soen is often cited by papers focused on Bone health and osteoporosis research (41 papers), Bone health and treatments (33 papers) and Bone Metabolism and Diseases (21 papers). Satoshi Soen collaborates with scholars based in Japan, United States and Netherlands. Satoshi Soen's co-authors include Saeko Fujiwara, Toshitsugu Sugimoto, Hiroshi Hagino, Hiroaki Ohta, Masataka Shiraki, Toshiyuki Yoneda, Masao Fukunaga, Takayuki Hosoi, Teruki Sone and Akira Taguchi and has published in prestigious journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and The EMBO Journal.

In The Last Decade

Satoshi Soen

80 papers receiving 2.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Satoshi Soen Japan	23	1.7k	1.2k	852	594	560	82	2.9k
Gerolamo Bianchi Italy	26	1.2k 0.7×	556 0.5×	421 0.5×	495 0.8×	362 0.6×	81	2.1k
Michael Maricic United States	22	1.7k 1.0×	1.2k 1.0×	863 1.0×	202 0.3×	445 0.8×	47	2.4k
Daniela Merlotti Italy	30	1.2k 0.7×	1.2k 1.0×	978 1.1×	457 0.8×	268 0.5×	94	2.9k
Michael Pazianas United Kingdom	28	1.0k 0.6×	1.1k 0.9×	801 0.9×	255 0.4×	281 0.5×	80	2.5k
David Hosking United Kingdom	28	2.4k 1.4×	2.4k 2.0×	959 1.1×	438 0.7×	465 0.8×	59	3.7k
Ronald Emkey United States	27	3.7k 2.2×	3.2k 2.6×	1.5k 1.8×	339 0.6×	577 1.0×	45	4.6k
Suresh Siddhanti United States	24	3.2k 1.9×	2.9k 2.4×	2.3k 2.7×	339 0.6×	660 1.2×	54	4.7k
Polyzois Makras Greece	31	1.3k 0.8×	1.4k 1.1×	1.2k 1.4×	226 0.4×	695 1.2×	149	3.4k
Harold N. Rosen United States	25	1.4k 0.8×	789 0.6×	672 0.8×	161 0.3×	393 0.7×	68	2.6k
Ann E. Kearns United States	23	839 0.5×	759 0.6×	831 1.0×	149 0.3×	435 0.8×	55	2.2k

Countries citing papers authored by Satoshi Soen

Since Specialization

Citations

This map shows the geographic impact of Satoshi Soen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Satoshi Soen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Satoshi Soen more than expected).

Fields of papers citing papers by Satoshi Soen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Satoshi Soen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Satoshi Soen. The network helps show where Satoshi Soen may publish in the future.

Co-authorship network of co-authors of Satoshi Soen

This figure shows the co-authorship network connecting the top 25 collaborators of Satoshi Soen. A scholar is included among the top collaborators of Satoshi Soen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Satoshi Soen. Satoshi Soen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Tanaka, Shiro, et al.. (2025). Evaluation of the fracture prevention effects of teriparatide and alendronate in patients with frailty: a sub-analysis of the Japanese osteoporosis intervention trial-05. Journal of Bone and Mineral Metabolism. 43(4). 448–457. 1 indexed citations

Takeuchi, Yasuhiro, Shiro Tanaka, Tatsuhiko Kuroda, et al.. (2024). Predictors of discontinuation of osteoporosis treatment: sub-analysis of the Japanese osteoporosis intervention trial-05 (JOINT-05). Journal of Bone and Mineral Metabolism. 42(6). 675–680. 3 indexed citations

Soen, Satoshi, Yukari Uemura, Shiro Tanaka, et al.. (2024). A crossover comparison of patient satisfaction with two teriparatide regimens: primary results of the Japanese Osteoporosis Intervention Trial 06 (JOINT-06). Journal of Bone and Mineral Metabolism. 42(5). 582–590. 1 indexed citations

Ohta, Hiroaki, Yukari Uemura, Teruki Sone, et al.. (2023). Effect of Bone Resorption Inhibitors on Serum Cholesterol Level and Fracture Risk in Osteoporosis: Randomized Comparative Study Between Minodronic Acid and Raloxifene. Calcified Tissue International. 112(4). 430–439. 6 indexed citations

Taguchi, Akira, Shiro Tanaka, Satoshi Mori, et al.. (2023). Reliability of early stage symptoms/clinical findings of osteonecrosis of the jaw: Japanese Osteoporosis Intervention Trial-05 (JOINT-05). Journal of Bone and Mineral Metabolism. 41(6). 854–864. 1 indexed citations

Hagino, Hiroshi, Toshitsugu Sugimoto, Shiro Tanaka, et al.. (2021). A randomized, controlled trial of once-weekly teriparatide injection versus alendronate in patients at high risk of osteoporotic fracture: primary results of the Japanese Osteoporosis Intervention Trial-05. Osteoporosis International. 32(11). 2301–2311. 35 indexed citations

Tanaka, Yoshiya, Satoshi Soen, Naoki Ishiguro, et al.. (2020). Identifying the preferable rheumatoid arthritis subgroups for intervention with the anti-RANKL antibody denosumab to reduce progression of joint destruction. RMD Open. 6(2). e001249–e001249. 7 indexed citations

Soen, Satoshi, Kazuhiko Yamamoto, Tsutomu Takeuchi, et al.. (2020). Minodronate combined with alfacalcidol versus alfacalcidol alone for glucocorticoid-induced osteoporosis: a multicenter, randomized, comparative study. Journal of Bone and Mineral Metabolism. 38(4). 511–521. 4 indexed citations

Soen, Satoshi, et al.. (2020). A 3-year postmarketing study on the safety and effectiveness of once-monthly risedronate in Japanese patients with osteoporosis. SHILAP Revista de lepidopterología. 6(4). 191–198. 2 indexed citations

10.

Tanaka, Ikuko, Yoshiya Tanaka, Satoshi Soen, & Hisaji Oshima. (2020). Efficacy of once-weekly teriparatide in patients with glucocorticoid-induced osteoporosis: the TOWER-GO study. Journal of Bone and Mineral Metabolism. 39(3). 446–455. 9 indexed citations

11.

Takeuchi, Tsutomu, Yoshiya Tanaka, Satoshi Soen, et al.. (2019). Effects of the anti-RANKL antibody denosumab on joint structural damage in patients with rheumatoid arthritis treated with conventional synthetic disease-modifying antirheumatic drugs (DESIRABLE study): a randomised, double-blind, placebo-controlled phase 3 trial. Annals of the Rheumatic Diseases. 78(7). 899–907. 108 indexed citations

12.

Soen, Satoshi, Hideaki Kishimoto, Hiroshi Hagino, et al.. (2019). Phase II/III, randomized, double-blind, parallel-group study of monthly delayed-release versus daily immediate-release risedronate tablets in Japanese patients with involutional osteoporosis. Journal of Bone and Mineral Metabolism. 38(1). 86–98. 1 indexed citations

13.

Taguchi, Akira, Masataka Shiraki, Satoshi Soen, et al.. (2015). Impact of Osteonecrosis of the Jaw on Osteoporosis Treatment in Japan: Results of a Questionnaire-Based Survey by the Adequate Treatment of Osteoporosis (A-TOP) Research Group. Calcified Tissue International. 97(6). 542–550. 20 indexed citations

14.

Soen, Satoshi. (2014). [Diagnostic criteria for primary osteoporosis : year 2012 revision].. PubMed. 24(3). 323–9. 12 indexed citations

15.

Kawaguchi, Isao, Isao Kamae, Satoshi Soen, & Choitsu Sakamoto. (2014). Cost-Effectiveness Analysis of Celecoxib in the Treatment of Patients with Chronic Pain in Japan. Iryo To Shakai. 24(3). 289–302. 2 indexed citations

16.

Kawaguchi, Isao, Isao Kamae, Satoshi Soen, & Choitsu Sakamoto. (2014). Cost-Effectiveness Analysis of Celecoxib In the Treatment of Patients With Chronic Pain In Japan. Value in Health. 17(7). A533–A533. 1 indexed citations

17.

Ishijima, Muneaki, Tomohiro Nakamura, Katsuji Shimizu, et al.. (2013). Different changes in the biomarker CTX-II following intra-articular injection of high molecular weight hyaluronic acid and oral non-steroidal anti-inflammatory drugs for patients with knee osteoarthritis: a multi-center randomized controlled study. Osteoarthritis and Cartilage. 21. S292–S292. 3 indexed citations

18.

Yoneda, Toshiyuki, Hiroshi Hagino, Toshitsugu Sugimoto, et al.. (2010). Bisphosphonate-related osteonecrosis of the jaw: position paper from the Allied Task Force Committee of Japanese Society for Bone and Mineral Research, Japan Osteoporosis Society, Japanese Society of Periodontology, Japanese Society for Oral and Maxillofacial Radiology, and Japanese Society of Oral and Maxillofacial Surgeons. Journal of Bone and Mineral Metabolism. 28(4). 365–383. 208 indexed citations

19.

Soen, Satoshi. (2009). [New development in bisphosphonate treatment. Bisphosphonates for the treatment of glucocorticoid-induced osteoporosis].. PubMed. 19(1). 44–53. 1 indexed citations

20.

Soen, Satoshi. (2005). [Management of glucocorticoid-induced osteoporosis].. PubMed. 15(4). 616–24. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact